ArticlePDF Available

Evaluation of Incidence, Genotypes, and Risk Factors Associated with Newly Diagnosed Hepatitis C Cases in Khyber Pakhtunkhwa (KPK), Pakistan

Authors:

Abstract and Figures

Hepatitis C is a global health concern brought on by the hepatitis C virus (HCV). The risk factors of the disease include injection drug users, contaminated medical instruments, blood transfusion, organ transplant, major surgery, dialysis, dental surgery, and acupuncture. The aim of the current study was to identify the prevalence of active HCV infection, genotypes, and their associated risk factors in newly infected patients of Khyber Pakhtunkhwa (KPK), Pakistan. A total of 230 HCV cases and 245 control subjects were enrolled. Our findings revealed that disease infection rates were higher in female patients (52.6%) than male patients (47.4%). Moreover, the disease was more prevalent in the age group 30–40 years (39.6%). The highest incidence was found in the southern region (51.30%), followed by the northern region (27.82%), and central region (18.26%). In our data set, dental surgery, major surgery, disease in family, barber community, blood received, needles, abroad travel, injection drug users, acupuncture, and organ transplantation were determined as the major associated risk factors of the disease. Odds ratio were significantly higher (10.91%) for those who used acupuncture as compared to those who did not. Similarly, odds were significantly higher (10.03%) for those who had HCV in their family, dialysis (9.377%), dental surgery (7.618%), major surgery (6.813%), barber community (5.328%), and blood received (2.252%) as compared to the control group. Also, the most frequent genotype was 3a (63%), followed by an un-typeable genotype (11.30%).
Content may be subject to copyright.
Current Trends in OMICS(CTO)
Volume 2 Issue 1, Spring 2022
ISSN(P): 2790-8283 ISSN(E): 2790-8291
Homepage: https://journals.umt.edu.pk/index.php/cto
Article QR
A publication of
Department of Life Sciences, School of Science
University of Management and Technology, Lahore, Pakistan
Title:
Evaluation of Incidence, Genotypes, and Risk Factors Associated with Newly
Diagnosed Hepatitis C Cases in Khyber Pakhtunkhwa (KPK), Pakistan
Author (s):
Ubaid Ahmad1, Najeeb Ullah Khan1, Maaz Iqbal1, Muhammad Ismail2, Adeela
Mustafa3
Affiliation (s):
1The University of Agriculture Peshawar, Pakistan
2Department of Zoology, Islamia College Peshawar
3Khyber Medical Collage
DOI:
https://doi.org/10.32350/cto.21.02
History:
Received: April 28, 2022, Revised: May 26, 2022, Accepted: June 08, 2022
Citation:
Ahmad U, Khan NU, Iqbal M, Ismail M, Mustafa A. Evaluation of incidence,
genotypes and risk factors of newly diagnosed Hepatitis C cases in Khyber
Pakhtunkhwa, Pakistan. BioSci Rev. 2022;2(1):1734.
https://doi.org/10.32350/cto.21.02
Copyright:
© The Authors
Licensing:
This article is open access and is distributed under the terms of
Creative Commons Attribution 4.0 International License
Conflict of
Interest:
Author(s) declared no conflict of interest
Research Article
18
Current Trends in OMICS
Journal of Management and
Research
Volume 2 Issue 1, 2022
Evaluation of Incidence, Genotypes, and Risk Factors
Associated with Newly Diagnosed Hepatitis C Cases in
Khyber Pakhtunkhwa (KPK), Pakistan
Ubaid Ahmad1, Najeeb Ullah Khan1, Maaz Iqbal1, Muhammad Ismail2, Adeela
Mustafa3
1The University of Agriculture Peshawar, Pakistan
2Department of Zoology, Islamia College, Peshawar
3Khyber Medical Colege
Abstract
Hepatitis C is a global health concern brought on by the hepatitis C virus
(HCV). The risk factors of the disease include injection drug users,
contaminated medical instruments, blood transfusion, organ transplant,
major surgery, dialysis, dental surgery, and acupuncture. The aim of the
current study was to identify the prevalence of active HCV infection,
genotypes, and their associated risk factors in newly infected patients of
Khyber Pakhtunkhwa (KPK), Pakistan. A total of 230 HCV cases and 245
control subjects were enrolled. Our findings revealed that disease
infection rates were higher in female patients (52.6%) than male patients
(47.4%). Moreover, the disease was more prevalent in the age group 30
40 years (39.6%). The highest incidence was found in the southern region
(51.30%), followed by the northern region (27.82%), and central region
(18.26%). In our data set, dental surgery, major surgery, disease in
family, barber community, blood received, needles, abroad travel,
injection drug users, acupuncture, and organ transplantation were
determined as the major associated risk factors of the disease. Odds ratio
were significantly higher (10.91%) for those who used acupuncture as
compared to those who did not. Similarly, odds were significantly higher
(10.03%) for those who had HCV in their family, dialysis (9.377%), dental
surgery (7.618%), major surgery (6.813%), barber community (5.328%),
and blood received (2.252%) as compared to the control group. Also, the
most frequent genotype was 3a (63%), followed by an un-typeable
genotype (11.30%).
Keywords: hepatitis C virus (HCV), blood transfusion, dialysis, genotype,
surgery
*Coresponding Author: najeebkhan@aup.edu.pk ; adeelaamir@gmail.com
Ahmed et al.
19
Department of Knowledge and Research Support
Services
Volume 2 Issue 1, 2022
Introduction
Chronic hepatitis C virus (HCV) infection is a worldwide health hazard
[1] associated with a variety of hepatic and extrahepatic illnesses,
including cancer. Hepatitis is a contagious blood viral disease caused by
HCV [2]. HCV belongs to hepaciviral genus of Flaviviridea family and
was discovered in 1989. It has a positive-sense, single-stranded RNA
genome with a size of 9.5Kb that codes for a polyprotein of 30003030
amino acids [3]. The infective virus leads to the inflammation of the liver,
manifested by the inflammatory cells in the infected liver tissue, which
may progress to fibrosis, followed by cirrhosis, hepatic cellular carcinoma
(HCC) (end stage of liver condition), and death [4]. HCV causes HCC by
regulating various indirect mechanisms [5]. For instance, the polyprotein
is processed by host and viral proteases which construct mature structural
and non-structural (NS) proteins [6]. HCV core protein enters the host cell
[7], where it remains present in the outside mitochondrial membrane and
endoplasmic reticulum, which enhances oxidative stress. It results in the
activation of key signaling pathways, such as the nuclear factor kappa B
and p38 mitogen-activated protein kinase pathways [8], directing the over
expression of genes involved in cytokine production and inflammation,
changes in apoptotic pathways, and tumor formation. The non-structural
proteins of HCV, NS3, and NS5A act as mediators to create oxidative
stress and inflammation.
The ideal transmission mode of HCV is either through blood or blood-
related products. It was noticed that the supply of blood was contaminated
with an unidentified agent causing post-transfusion non-A and non-B
hepatitis [9]. In developed countries, post-transfusion hepatitis C has
become relatively rare. The incidence of transfusion associated hepatitis,
traced from 1970 to 1998, decreased from 33% to the nearly eliminated
HCV transmission caused by the effectiveness of a series of donor
screening interventions [10]. In developing countries, where HCV testing
of donated blood is not feasible, receiving blood items remains a dominant
source of HCV infection. The prevalence of anti-HCV among intravenous
drug users ranged from 31% to 98% [11]. It has been reported that
injection drug use accounts for 60% and 80% of HCV infections in USA
[12] and Australia, respectively [13]. In developing countries, HCV
transmission is mainly via unsafe therapeutic injections [14] resulting in
2.34 million HCV infections every year, approximately [15]. The
Evaluation of Incidence Genotype
20
Current Trends in OMICS
Journal of Management and
Research
Volume 2 Issue 1, 2022
transmission of HCV through unhygienic injection equipment has been an
issue in most developing countries [16]. Other sources of HCV
transmission [17] include activities involving the potential for
percutaneous exposure to blood or blood derived body fluids, such as
tattooing [18], acupuncture [19], sharing cottons [20], and other
biologically plausible modes of transmission including body piercing,
cosmetic procedures, and commercial barbering [21].
HCV has six major genotypes and eighty subtypes with their specific
sequences [22], [23], [24]. HCV genotypes 1, 2, and 3 are found
throughout the world, while their relative prevalence differs from place to
place. HCV genotype 1 is the most common genotype, accounting for 83.4
million cases (46.2% of all HCV cases), worldwide. HCV genotype 3 is
the next most prevalent genotype with 54.3 million cases (30.1%),
worldwide. In Nepal [25], India [26], and Pakistan [27], HCV-3
(predominantly 3a) is the most common genotype [28]. The high
incidence of HCV genotype 3 is a serious concern because compared to
other genotypes, genotype 3 is associated with a higher risk of liver
consequences and overall mortality in all HCV patients [29]. In the current
study, we aimed to find the incidence of active HCV infection and
associated risk factors in newly infected individuals among the population
of Khyber Pakhtunkhwa (KPK), Pakistan.
Materials And Methods
Study Design and Sampling
In this cohort study, a total of 230 HCV cases and 245 healthy control
subjects were enrolled. All the patients and healthy blood donors were
recruited from Khyber Teaching Hospital (KTH), Peshawar. Ethical
approval from the competent authority of KTH was taken along with the
written consent of the patients. The objectives of the study were explained
to the patients before taking their data. Demographic data, such as age,
home town, locality, economic status, and time period of the disease were
collected via a standard questionnaire along with 23 CC blood.
Hepatitis C Virus Screening
All the samples were screened for anti-HCV using ICT (Immuno-
Chromatographic test), ELISA (Enzyme Linked Immune Sorbent Assay)
and RT (Real Time PCR).
Ahmed et al.
21
Department of Knowledge and Research Support
Services
Volume 2 Issue 1, 2022
HCV Genotyping
The anti-HCV PCR-positive patients were further subjected to HCV
genotyping. /Complete follow up was conducted of all the pateints. The
results were obtained in the form of a document to find out their respective
genotypes. HCV genotyping was peformed using real-time hybridization
fluorescence detection method. For subtyping, HCV RNA was reverse
transcribed into cDNA by using MMLV reverse transcriptase enzyme. The
cDNA was subjected to two rounds of PCR amplification. PCR products
were electrophoresed on 2% agarose gel, stained with ethidium bromide,
and visualized on UV transilluminator.
Statistical Analysis
The odds ratio and significance level of all the possible risk factors were
assessed by using binary logistic regression view via the Statistical
Package for Social Sciences (IBM SPSS STATISTICS V20). One-way
ANOVA was carried out to determine the differences between the
different conditions (age, gender, and other parameters) of patients and
control.
Results
Demographic Characteristics of HCV Positive Cases
A total of 300 newly infected patients and 245 healthy controls were
questioned and conveniently sampled for the current study. Out of 300
HCV infected cases, 230 were found to be positive for HCV using ICT,
ELISA, and PCR, of which 121 were female and 109 were male patients
(Table 1). Based on age difference, patients were categorized into five
different age groups, namely below 30 years, 3140 years, 4150 years,
5160 years, and above 60 years. Our results indicated that HCV infection
was high in age group 3140 (35.2%), followed by age group 4150
(23.5%) (Table 2).
Evaluation of Incidence Genotype
22
Current Trends in OMICS
Journal of Management and
Research
Volume 2 Issue 1, 2022
Table 1: Gender-wise Distribution of HCV Positive Cases
Count
Total
Afghanistan
Southern
KP
Northern
KP
Central
KP
Gender
Female
2
14
35
70
121
Male
4
28
29
48
109
Total
6
42
64
118
230
Table 2: Age-wise Distribution of HCV Positive Cases
Age-group
No. of samples
Male
Female
Below 30
45 (19.6%)
20 (18.3)
25 (20.6)
31-40
81 (35.2%)
33 (30.2)
48 (39.6)
41-50
54 (23.5%)
25 (22.9)
29 (23.9)
51-60
38 (16.5%)
21 (19.2)
17 (14.04)
Above 60
12 (15.3%)
10 (9.17)
2 (1.6)
Total
230
109
121
Odds Ratio (OR) in Relation to HCV Risk Factors
The odds ratio and significance level of all possible risk factors were
assessed via simple and forward selection using binary logistic regression
view through Statistical Package for Social Sciences (IBM SPSS
STATISTICS V20). The package was used to analyze and find out the
percept distribution of qualitative records the various infected patients and
control group. The results revealed that the following categorical variables
(Table 3a, 3b, 3c) as significant risk factors in comparison to control. The
odds showed that the disease causing factors were statistically associated
with HCV transmission. The odds were significantly higher (10.91%) for
those patients who used acupuncture and were HCV positive as compared
to control, followed by patients with HCV in the family (10.03%), dialysis
(9.377%), dental surgery (7.628%), major surgery (6.813%), barber
community (5.328%), and blood received (2.25%).
Table 3a. Dependent Variables in Coding
Original Value
Inner Value
Yes
1
No
0
Ahmed et al.
23
Department of Knowledge and Research Support
Services
Volume 2 Issue 1, 2022
Table 3b. Coding of All Definite Variables
Frequency
Parameter coding
(1)
Travel Abroad
Yes
42
1.000
No
432
.000
Blood Received
Yes
69
1.000
No
405
.000
I-D-Users
Yes
38
1.000
No
436
.000
Smoking
Yes
65
1.000
No
409
.000
Needles
Yes
43
1.000
No
431
.000
Barber
Yes
61
1.000
No
413
.000
O. Transplantation
Yes
20
1.000
No
454
.000
Major Surgery
Yes
104
1.000
No
370
.000
Disease in family
Yes
88
1.000
No
386
.000
Piercing
Yes
20
1.000
No
454
.000
Acupuncture
Yes
27
1.000
No
447
.000
Dialysis
Yes
52
1.000
No
422
.000
Dental Surgery
Yes
108
1.000
No
366
.000
Table 3c. Definite Variables in Calculation
Variables
B
S.E.
Wald
Df
Sig.
Exp (B)
Blood Received
.812
.377
4.624
1
.032
2.25
Barber
1.673
.490
11.658
1
.001
5.328
Major Surgery
1.919
.330
33.728
1
.000
6.813
Dental Surgery
2.030
.330
37.865
1
.000
7.618
Dialysis
2.238
.619
13.082
1
.000
9.377
Acupuncture
2.389
.883
7.329
1
.007
10.907
Disease in family
2.306
.378
37.113
1
.000
10.031
Constant
-2.151
.215
100.408
1
.000
.116
Evaluation of Incidence Genotype
24
Current Trends in OMICS
Journal of Management and
Research
Volume 2 Issue 1, 2022
Possible Risk Factors for HCV Transmission
A basic objective of our study was to find out the possible risk factors of
HCV transmission in the newly infected individuals. All the HCV infected
patients and also the control group were questioned as per the
questionnaire. The results revealed by applying descriptive statistics and
frequency was shown in the case study contatining the control group
also.the risk factors were significantly associated with HCV transmission
(Figure 1). Among all risk factors, dental surgery (37.39%) was found to
be the most possible route risk factor for HCV infection, followed by
major surgery (34.34%), HCV history in family (20.34%), barber
community (23.47%), blood received (23.04%), dialysis (20.86%),
needles reuse (16.08%), travel abroad (13.47%), ID-users (13.04),
acupuncture (10.86%), and organ transplantation (6.95%).
Figure 1. Possible Risk Factors for HCV Transmission in Khyber
Pakhtunkhwa
Frequency Distribution of HCV Genotypes
All HCV positive patients were assessed for HCV genotypes (Figure 2).
Out of 230 HCV samples, genotype 3a (63.04%) was found to be the most
abundant, followed by an un-typeable genotype (11.3%), 1a (9.1%), 2a
Ahmed et al.
25
Department of Knowledge and Research Support
Services
Volume 2 Issue 1, 2022
(6.5%), 3b (4.8%), 2b (1.3%), 1b+3a (1.30%), 1b (0.86%), 1a+3a (0.86%),
and 3a+3b (0.43%).
Figure 2. Frequency Distribution of HCV Genotypes
HCV RNA was reverse transcribed into cDNA by using MMLV reverse
transcriptase enzyme. The cDNA was subjected to two rounds of PCR
amplification, which utilized genotype specific primers.
Associated Risk Factors of HCV Genotype 3a and 3b
Demographic data showed a higher percentage of association between risk
factors and HCV genotype 3a. The high percentage of barber community
(72.2%) was found to be the main associated risk factor for genotype 3a
transmission, followed by dental surgery (65.1%), blood received from
infected individuals (62.3%), major surgery (62%), HCV in the family
(59.5%), dialysis (58.3%), and acupuncture (48%) (Figure 3a). A higher
percentage association was also observed between risk factors and HCV
genotype 3b. The percenatge of infected individuals who used acupuncture
(16%) was found to be the main association factor for HCV transmission,
followed by major surgery (7.6%), dental surgery (7%), dialysis (6.2%),
HCV in the family (4.1%), and barber community (1.9%) (Figure 3b).
Evaluation of Incidence Genotype
26
Current Trends in OMICS
Journal of Management and
Research
Volume 2 Issue 1, 2022
a) b)
Figure 3. Associated Risk Factors of HCV Genotypes 3a and 3b. a) Association between
various risk factors and 3a genotype. b) Association between various risk factors and 3b
genotype.
Associated Risk Factors of HCV Genotypes 2a and 2b
Demographic data showed a higher percentage association between risk
factors and HCV genotype 2a (Figure 4a). The percentage of infected
individuals with HCV in the family (9.5%) was found to be the main
associated factor for HCV transmission, followed by blood received
(9.4%), dental surgery (5.8%), dialysis (4.2%), acupuncture (4%), major
surgery (3.8%), and barber community (1.9%). Demographic data also
showed a higher percentage association between risk factors and HCV
genotype 2b (Figure 4b). The percentage of infected individuals who used
acupuncture (8%) was found to be the main associated factor for HCV
transmission, followed by dialysis (2.1%), blood received from infected
individuals (1.9%), and dental surgery (1.2%).
a) b)
Figure 4: Associated Risk Factors of HCV Genotypes 2a and 2b. a) Association between
various risk factors and 2a genotype. b) Association between various risk factors and 2b
genotype.
Ahmed et al.
27
Department of Knowledge and Research Support
Services
Volume 2 Issue 1, 2022
Associated Risk Factors of HCV Genotypes 1a and 1b
Demographic data showed a higher percentage association between risk
factors and HCV genotype 1a (Figure 5a). The percentage of patients
using dialysis (12.5%) was found to be the main associated risk factor for
HCV genotype 1a transmission, followed by blood received from infected
individuals (11.3%), individuals with HCV in the family (10.8%), major
surgery (7.6%), barber community (7.4%), dental surgery (5.8%), and
acupuncture (4%). The percentage of infected individuals who /belonged
to the same barber community (3.7%) was found to be the main associated
factor in genotype 1b transmission, followed by those who belonged to the
same dental surgery community (2.3%) (Figure 5b).
a) b)
Figure 5. Associated Risk Factors of HCV Genotypes 1a and 1b. a) Association between
various risk factors and genotype 1a. b) Association between various risk factors and
genotype 1b.
Associated Risk Factors of HCV Un-typeable and Mixed Genotypes
Demographic data showed a higher percentage association between risk
factors and un-typeable genotypes. The percentage of people using
acupuncture (20%) was found to be the main associated factor for un-
typeable genotype transmission, followed by major surgery community
(15.2%), infected individuals with HCV in the family (14.9%), dialysis
(14.6%), blood received from infected individuals (11.3%), barber
community (11.1%), and dental surgery (9.3%) (Figure 6a). A higher
percentage association was found between risk factors and HCV
genotypes 1b+3a. The percentage of infected individuals who underwent
dialysis (2.1%) was found to be main associated factor with genotypes
1b+3a transmission, followed by blood received (1.9%), barber
community (1.9%), major surgery (1.3%), and dental surgery (1.2%).
Evaluation of Incidence Genotype
28
Current Trends in OMICS
Journal of Management and
Research
Volume 2 Issue 1, 2022
Demographic data also showed a higher percentage association between
risk factors and HCV genotypes 3a+3b. The frequency of infected
individuals who underwent major surgery (1.3%) was found to be main
associated with genotypes 3a+3b transmission, followed by dental surgery
(1.2%), and blood received from infected individuals (1%).
a) b)
C)
Figure 6: Associated Risk Factors of HCV Un-typeable and Mixed Genotypes. a)
Association between various risk factors and un-typeable genotypes. b) Association
between various risk factors and 1b+3a genotypes. c) Association between various risk
factors and 3a+3b genotypes.
Discussion
Hepatitis is a transmissible blood viral ailment caused by the hepatitis C
virus (HCV). HCV is a worldwide health hazard related to numerous
hepatics and hepatic disorders, such as malignancies. The most essential
transmission modes of HCV are blood or blood associated products. The
known global risk factors of the disease include injection drug users,
contaminated medical instruments, blood transfusion, organ transplant,
major surgery, dialysis, household items, dental surgery, and acupuncture.
Ahmed et al.
29
Department of Knowledge and Research Support
Services
Volume 2 Issue 1, 2022
Numerus procedures have been adopted to control the disease, including
proper screening and awareness campaigns, both in health professionals
and general public. However, theworldwide situation of the disease is still
alarming, particularly in developing countries, such as Pakistan. In this
study, we aimed to find out the exact situation of risk factors in the newly
diagnosed cases of HCV. A total of 300 HCV cases and 245 healthy
individuals were included in the current study. Out of the 300 HCV cases,
230 samples were found to be positive for active HCV using ICT, ELISA,
and RT-PCR. Our data set showed that HCV infection occurred more in
female patients as compared to male patinets. Moreover, the disease was
more prevalent in age group 3140 years, followed by age group 4150
years (Table 2). Recently, a similar conclusion was reached by an author
from Pakistan [30]. Our results further showed that the most probable risk
factors of HCV cases were dental surgery, followed by major surgery, and
family history. These risk factors of HCV transmission have been very
well known for the last 23 decades [28], [31]. It indicates that in
Pakistan, there is a lack of proper guidelines for health professionals who
consequently indulge in malpractices, even though these risk factors have
been well known to everyone including the majority of the general public.
Government officials need to ensure compliance with proper and strict
guidelines for reusing the dental and surgical equipment.
The most prevalent genotype in our data set was 3a (63.04%), followed by
the un-typeable genotype (11.3%), 1a (9.1%), 2a (6.5%), 3b (4.8 %), 2b
(1.3%), 1b+3a (1.30%), 1b (0.86%), 1a+3a (0.86%), and 3a+3b (0.43%).
Similarly, a recent study conducted by Pakistani authors from 2015 to
2018 on HCV cirrhotic patients in Peshawar hospitals [32] concluded that
the prevalence of HCV genotype 3a was 47.9%, 2a and 3b was 11% each,
1a was 6%, and 1b was 1%; while, 4.1% had mixed genotypes and 18.7%
had un-typable genotypes. Additionally, HCV genotype 3 was identified
as the most common genotype in Bangladesh, Nepal, and India [25, 33,
34]. Our sample included a substantial proportion of un-typable genotypes
in contrast to the earlier findings..
Our study identified the higher percentage association between risk
factors and HCV genotype 3b. The percentage of infected individuals who
used acupuncture (16%) was found to be the main associated factor for
HCV transmission, followed by major surgery (7.6%), dental surgery
(7%), dialysis (6.2%), HCV in the family (4.1%), and barber community
Evaluation of Incidence Genotype
30
Current Trends in OMICS
Journal of Management and
Research
Volume 2 Issue 1, 2022
(1.9%). Our study also showed a higher percentage association between
risk factors and HCV genotype 3a+3b. The percentage of infected
individuals who underwent major surgery (1.3%) was found to be main
associated factor with genotype 3a+3b transmission, followed by dental
surgery (1.2%), and blood received from infected individuals (1%). Blood
transfusion, dangerous intravenous injection, and surgery are all instances
of unsafe medical procedures. However, many people acquire HCV while
visiting barber shops, beauty salons, and hair salons. A large percentage of
people denied ever having been exposed to HCV. Moreover, we found no
evidence of vertical transmission. A considerable number of HCV
infections occur outside of dangerous medical procedures incosmetics, as
well as hair and barber businesses. This is presumably a result of the use
of razors, clippers, cuticle pushers, nail files, nail buffers, brushes, or any
other piercing equipment.
However, additional nationwide investigations are still required to
provide a complete picture of the distribution of HCV genotypes in
association with gender, age, risk factors, and pretreatment viral load. The
results of this study clearly showed some gaps in the epidemiology of
HCV and its associated risk factors in the Khyber Pakhtunkhwa
population.
Conclusion
In contrast to the outcomes of our previous research conducted a decade
ago, the results showed that 3a is the most common HCV genotype.
Female patients were found to have a somewhat higher prevalence of
HCV. Moreover, the majority of those infected were middle-aged (30-40
years). The findings implicate that all high and extremely high viral loads
are frequently found in all genotypes, although the most prevalent subtype
3a is associated with low and intermediate viral loads. The majority of
people in Khyber Pakhtunkhwa contract HCV because international
standards are not being followed, especially when it comes to blood
transfusion and surgery. Prior knowledge of pretreatment viral load and
HCV genotype must be considered in national planning strategies, as it
would minimize the side effects of antiviral medication, reduce the
economic bioburden, and improve response rates.
Conflict of Interests
The authors have no conflict of interests.
Ahmed et al.
31
Department of Knowledge and Research Support
Services
Volume 2 Issue 1, 2022
Funding
The current work received no funding
References
1. Kondili, L.A., et al., Milestones to reach Hepatitis C Virus (HCV)
elimination in Italy: From free-of-charge screening to regional
roadmaps for an HCV-free nation. Digestive and Liver Disease, 2022.
54(2): p. 237-242.
2. Harris, M., et al., Conceptualising hepatitis C stigma: a thematic
synthesis of qualitative research. International Journal of Drug Policy,
2021. 96: p. 103320.
3. Choo, Q.-L., et al., Isolation of a cDNA clone derived from a blood-
borne non-A, non-B viral hepatitis genome. Science, 1989. 244(4902):
p. 359-362.
4. Umar, M. and M. Bilal, Hepatitis C, a mega menace: a Pakistani
perspective. J Pak Med Stud, 2012. 2(2): p. 68-72.
5. Wangensteen, K.J. and K.-M. Chang, Multiple roles for hepatitis B and
C viruses and the host in the development of hepatocellular carcinoma.
Hepatology (Baltimore, Md.), 2021. 73(Suppl 1): p. 27.
6. Chen, P.-J., et al., The Taiwanese hepatitis C virus genome: sequence
determination and mapping the 5′ termini of viral genomic and
antigenomic RNA. Virology, 1992. 188(1): p. 102-113.
7. Lee, J. and J.-H.J. Ou, Hepatitis C virus and intracellular antiviral
response. Current Opinion in Virology, 2022. 52: p. 244-249.
8. Wu, C.-H., et al., Revealing the suppressive role of protein kinase C
delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis
associates with lenvatinib-inhibited progression in hepatocellular
carcinoma in vitro and in vivo. Biomedicine & Pharmacotherapy, 2022.
145: p. 112437.
9. Khean-Lee, G., The 2017 M Balasegaram Memorial Lecture: The
Changing Landscape of Liver Diseases in Malaysia60 Years On!
MJMS-The Malaysian Journal of Medical Sciences, 2019. 26(2): p. 18-
29.
Evaluation of Incidence Genotype
32
Current Trends in OMICS
Journal of Management and
Research
Volume 2 Issue 1, 2022
10. Alter, H.J. and M. Houghton, Hepatitis C virus and eliminating post-
transfusion hepatitis. Nature medicine, 2000. 6(10): p. 1082-1086.
11. Menon, K.V.N., et al., Treatment of posttransplantation recurrence of
hepatitis C with interferon and ribavirin: lessons on tolerability and
efficacy. Liver Transplantation, 2002. 8(7): p. 623-629.
12. Alter, M.J., et al., The prevalence of hepatitis C virus infection in the
United States, 1988 through 1994. New England journal of medicine,
1999. 341(8): p. 556-562.
13. Gaughwin, M., et al., Prevalence of hepatitis C infection in pregnant
women in South Australia. 1997.
14. Sun, Z., et al., Increased risk of hepatocellular carcinoma in male
hepatitis B surface antigen carriers with chronic hepatitis who have
detectable urinary aflatoxin metabolite M1. Hepatology, 1999. 30(2): p.
379-383.
15 Kane, A., et al., Transmission of hepatitis B, hepatitis C and human
immunodeficiency viruses through unsafe injections in the developing
world: model-based regional estimates. Bulletin of the World Health
Organization, 1999. 77(10): p. 801.
16. Chowdhury, A., et al., Hepatitis C virus infection in the general
population: a community-based study in West Bengal, India.
Hepatology, 2003. 37(4): p. 802-809.
17. Schmidbauer, C., et al., Epidemiological trends in HCV transmission
and prevalence in the Viennese HIV+ population. Liver International,
2020. 40(4): p. 787-796.
18. Pérez, C.M., et al., Seroprevalence of hepatitis C virus and associated
risk behaviours: a population-based study in San Juan, Puerto Rico.
International journal of epidemiology, 2005. 34(3): p. 593-599.
19. Shin, H.R., et al., Prevalence and risk factors of hepatitis C virus
infection among Koreans in rural area of Korea. Hepatology Research,
2000. 17(3): p. 185-196.
20. Hagan, H., et al., Syringe exchange and risk of infection with hepatitis
B and C viruses. American journal of epidemiology, 1999. 149(3): p.
203-213.
Ahmed et al.
33
Department of Knowledge and Research Support
Services
Volume 2 Issue 1, 2022
21. Shepard, C.W., L. Finelli, and M.J. Alter, Global epidemiology of
hepatitis C virus infection. The Lancet infectious diseases, 2005. 5(9):
p. 558-567.
22. Davarpanah, M., et al., Hepatitis C virus genotype distribution in
Shiraz, southern Iran. Hepatitis Monthly, 2009. 9(2): p. 122-127.
23. Ross, R., et al., Changes in the epidemiology of hepatitis C infection in
Germany: shift in the predominance of hepatitis C subtypes. Journal of
medical virology, 2000. 60(2): p. 122-125.
24. Okamoto, H., et al., Typing hepatitis C virus by polymerase chain
reaction with type-specific primers: application to clinical surveys and
tracing infectious sources. Journal of General Virology, 1992. 73(3): p.
673-679.
25. Tokita, H., et al., Hepatitis C virus variants from Nepal with novel
genotypes and their classification into the third major group. Journal of
general virology, 1994. 75(4): p. 931-936.
26. Singh, S., V. Malhotra, and S.K. Sarin, Distribution of hepatitis C virus
genotypes in patients with chronic hepatitis C infection in India.
INDIAN JOURNAL OF MEDICAL RESEARCH., 2004. 119: p. 145-
148.
27. Idrees, M. and S. Riazuddin, Frequency distribution of hepatitis C virus
genotypes in different geographical regions of Pakistan and their
possible routes of transmission. BMC infectious diseases, 2008. 8(1): p.
1-9.
28. SHAH, H.A., et al., Hepatitis C virus (HCV) genotypes and chronic
liver disease in Pakistan. Journal of gastroenterology and hepatology,
1997. 12(11): p. 758-761.
29. Kanwal, F., et al., Increasing prevalence of HCC and cirrhosis in
patients with chronic hepatitis C virus infection. Gastroenterology,
2011. 140(4): p. 1182-1188. e1.
30. Ahsan, A., et al., Estimation of hepatitis C prevalence in the Punjab
province of Pakistan: a retrospective study on general population. PloS
one, 2019. 14(4): p. e0214435.
Evaluation of Incidence Genotype
34
Current Trends in OMICS
Journal of Management and
Research
Volume 2 Issue 1, 2022
31. Kassaian, N., et al., Hepatitis C virus and associated risk factors among
prison inmates with history of drug injection in Isfahan, Iran.
International Journal of Preventive Medicine, 2012. 3(Suppl1): p. S156.
32. Ullah, A., et al., Hepatitis-C Virus and Cirrhosis: An Overview from
Khyber Pakhtunkhwa Province of Pakistan. Viral Immunology, 2020.
33(5): p. 396-403.
33. Narahari, S., et al., Prevalence and geographic distribution of Hepatitis
C Virus genotypes in Indian patient cohort. Infection, Genetics and
Evolution, 2009. 9(4): p. 643-645.
34. Rogers, G., et al., Surveillance of cirrhosis for hepatocellular
carcinoma: systematic review and economic analysis. Health
technology assessment (Winchester, England), 2007. 11(34): p. 1-206.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background Stigma is an important element in the experience of living with chronic viral hepatitis B (HBV) and C (HCV), impacting healthcare access and uptake as well as health outcomes. Conceptualisations of stigma in research are, however, often assumed and implicit. This study aimed to synthesise and critically engage with the qualitative literature to provide an overarching conceptualisation of stigma as it pertains to viral hepatitis. Methods We critically reviewed qualitative literature that mobilised concepts or theories of stigma in relation to viral hepatitis. We searched seven electronic databases for peer-reviewed literature from 2000 to 2019. Given a dearth of conceptual literature on HBV stigma, we conducted a thematic analysis of concepts deployed to theorise stigma in relation to HCV. Results We found 13 studies that conceptualised stigma in relation to HCV, yet none for HBV. We synthesise the analytical findings of these studies and explore how HCV is theorised in relation to four themes: ‘identity’, ‘embodiment’, ‘institutionalisation’, and ‘structuration’. Taken together, these themes illustrate the way in which HCV stigma manifests as the confluence of normative assumptions of socially unacceptable practices relating to HCV, such as injecting drug use and sexual behaviours; attitudes towards socially excluded populations; and fears of contracting a contagious and chronic illness. As such, operating within political, social, and economic systems, HCV stigma can act to silence the needs of those with HCV through misrecognising the multifaceted identities of individuals with HCV and structural determinants of health. Stigma, which is built and perpetuated by institutional arrangements, as well as in social processes and policies, shapes deservedness to, as well as engagements with, health and social care. Conclusion While commonly employed as a framing concept, much research lacks explicit theoretical or critical engagement on how stigma is conceptualised. There is a tendency for qualitative, empirical research to focus on risk factors shaping individual behaviour change, rather than on risk contexts and socio-structural change. Approaches to address stigma in relation to HCV must consider how stigma operates throughout social processes and is embedded in systems of power and normalised in institutional operating systems.
Article
Full-text available
Although Italy has been on track for Hepatitis C Virus (HCV) elimination since 2019, it fell off track due to the decrease in the number of treated patients. HCV elimination in Italy will be possible if immediate action is taken. A health policy was implemented beginning in 2021, consisting of screening among key populations and birth cohorts (1969-1989), estimated to have a high prevalence of undiagnosed individuals. The active screening requires regional governance that manages the processes' complexity integrating a well-organized network between territory assistance and hospital to achieve an effective HCV care cascade. This document aims to support the regional decision-making process by defining paths for screening and linkage-to-care. Implementing active screening strategies beyond a risk-based approach is required as a General Practitioners' task. Simplified paths must be drawn for the key populations screening. The infrastructure built for COVID-19 vaccination could be used also for HCV screening. According to a multidisciplinary care delivery, screening should be supplemented with rapid linkage-to-care and treatment of newly diagnosed patients. The realization of the proactive screening during the first two years is vital because it will define the tracks for the whole HCV cost-effective screening of 1948-1988 birth cohorts in Italy.
Article
Full-text available
Hepatitis C virus (HCV) leads to liver cirrhosis and carcinoma worldwide. The data of HCV cirrhotic patients were collected from hospitals of Peshawar in the period from 2015 to 2018. A total sample of 267 patients, in the age limit (>19 and <87 years) were found to be cirrhotic and HCV positive. The samples were analyzed through different tests, that is, raised alkaline phosphatase (410 IU/L), aspartate aminotransferase (209 U/L), and reverse transcription-polymerase chain reaction (PCR) viral load (>5,000,000 IU/mL). The mean and standard deviation (SD) of alanine transaminase and alpha fetoprotein were noted, (121.46 ± 29.23) and (43.09 ± 28.08), respectively. Samples of HCV cirrhotic patients (59.6% males and 40.4% females) were included and their mean age and SD of the patients was 49.62 ± 12.65 years. The Child-Turcotte-Pugh Score system was assessed on the base of liver disease. High blood pressure was observed in 26.2%, low in 40.8%, and normal in 33% of patients. The ascites was recorded high in 59% patients (male 38.6%, female 20.6%) and the level of albumin was abnormal in 64.5% patients. Furthermore, multiplex PCR was run to determine HCV genotypes. The frequency of HCV genotype 3a was 47.9%, 2a and 3b was 11%, 1a was 6%, and 1b was 1%; 4.1% were mixed genotypes and 18.7% were untypable genotypes in these patients. The HCV genotype 3a was found a major prevalent genotype in Khyber Pakhtunkhwa patients and it was observed that the HCV cirrhosis issue was significantly increased in the province.
Article
Full-text available
Background & aims: HIV/HCV coinfection is common in people who inject drugs (PWIDs). Recently, 'high-risk' behavior among men who have sex with men (MSM) has emerged as another main route of HCV transmission. We analyzed temporal trends in HCV epidemiology in a cohort of Viennese HIV+ patients. Methods: HCV parameters were recorded at HIV diagnosis (baseline, BL) and last visit (follow-up, FU) for all HIV+patients attending the HIV clinic between January-2014 and December-2016. Proportions of HIV+patients with anti-HCV(+) and HCV viremia (HCV-RNA(+)) at BL/FU were assessed and stratified by route of transmission. Results: 1806/1874(96.4%) HIV+patients were tested for HCV at BL. Anti-HCV(+) was detected in 93.2%(276/296) of PWIDs and in 3.7%(31/839) of MSM. After a median follow-up of 6.9 years, 1644(91.0%) patients underwent FU HCV-testing: 167(90.3%) of PWIDs and 49(6.7%) of MSM showed anti-HCV(+). Among 208 viremic (HCV-RNA(+)) patients at BL, 30(14.4%) had spontaneously cleared HCV, 76(36.5%) achieved treatment-induced eradication and 89(42.8%) remained HCV-RNA(+) at FU. Among 1433 initially HCV-naive patients, 45(3.5%) acquired de-novo HCV infection (11.1% PWIDs/80.0% MSM; incident rate (IR) 0.004%; 95%CI 0.0-0.022%)) and 14 had HCV reinfections (85.7% PWIDs/14.3% other; IR 0.001%; 95%CI 0.0-0.018%)) during a median FU of 6.7 years (IQR 7.4). Conclusion: HCV testing was succesfully implemented in the Viennese HIV(+) patients. Anti-HCV(+) prevalence remained stable in HIV+PWIDs but almost doubled in HIV+MSM. De-novo HCV infection occurred mostly in MSM, while HCV reinfections were mainly observed in PWIDs. HCV treatment uptake was suboptimal with 42.8% remaining HCV-RNA(+) at FU.
Article
Full-text available
The landscape of liver diseases in Malaysia has changed dramatically since the time of Professor Balasegaram Manickavasagar—an eminent surgeon in the 1960s. The most significant discoveries in hepatology have been that of hepatitis B virus in 1963 and hepatitis C virus in 1989, which have both been shown to be predominantly blood borne diseases. Hepatitis B and C infections result in long term carrier state and a high propensity to develop liver cirrhosis and cancer. Hepatitis B is the most common cause of liver cirrhosis and cancer in Malaysia. Blood bank screening and public health preventive measures have reduced the disease burden significantly and an effective vaccination for hepatitis B is now incorporated in our National Immunisation Programme. Although no vaccine is available for hepatitis C, highly effective eradication therapies were introduced in 2011. These agents will significantly change the disease scenario across the world. A “new” disease was described in 1980, by Ludwig et al.—non-alcoholic fatty liver (NAFLD) disease. With the global epidemic of obesity and diabetes mellitus, NAFLD is set to increase exponentially across the world including in Malaysia. It will be the most important liver disease in the future, replacing hepatitis B and C infections.
Article
Full-text available
Background Hepatitis C virus (HCV) infections are amongst the leading public health concerns in Pakistan with a high disease burden. Despite the availability of effective antiviral treatments in the country the disease burden in general population has not lowered. This could be attributed to the asymptomatic nature of this infection that results in lack of diagnosis until the late symptomatic stage. To better estimate and map HCV infections in the country a population-based analysis is necessary for an effective control of the infection. Methods Serologic samples of ~66,000 participants from all major cities of the Punjab province were tested for anti-HCV antibodies. The antibody-based seroprevalence was associated with socio-demographic variables including geographical region, age, gender and sex, and occupation. Results Overall serological response to HCV surface antigens was observed in over 17% of the population. Two of the districts were identified with significantly high prevalence in general population. Analysis by occupation showed significantly high prevalence in farmers (over 40%) followed by jobless and retired individuals, laborers and transporters. A significant difference in seroprevalence was observed in different age groups amongst sex and genders (male, female and transgender) with highest response in individuals of over 40 years of age. Moreover, most of the tested IDUs showed positive response for anti-HCV antibody. Conclusion This study represents a retrospective analysis of HCV infections in general population of the most populated province of Pakistan to identify socio-demographic groups at higher risk. Two geographical regions, Faisalabad and Okara districts, and an occupational group, farmers, were identified with significantly high HCV seroprevalence. These socio-demographic groups are the potential focused groups for follow-up studies on factors contributing to the high HCV prevalence in these groups towards orchestrating effective prevention, control and treatment.
Article
To establish successful infection in cells, it is essential for hepatitis C virus (HCV) to overcome intracellular antiviral responses. The host cell mechanism that fights against the virus culminates in the production of interferons (IFNs), IFN-stimulated genes (ISGs) and pro-inflammatory cytokines as well as the induction of autophagy and apoptosis. HCV has developed multiple means to disrupt the host signaling pathways that lead to these antiviral responses. HCV impedes signaling pathways initiated by pattern-recognition receptors (PRRs), usurps and uses the antiviral autophagic response to enhance its replication, alters mitochondrial dynamics and metabolism to prevent cell death and attenuate IFN response, and dysregulates inflammasomal response to cause IFN resistance and immune tolerance. These effects of HCV allow HCV to successful replicate and persist in its host cells.
Article
Nuclear factor-kappa B (NF-κB), an oncogenic transcription factor, modulates tumor formation and progression by inducing the expression of oncogenes involved in proliferation, survival, angiogenesis, and metastasis. Oral multikinase inhibitors, such as sorafenib, regorafenib, and lenvatinib have been used for the treatment of hepatocellular carcinoma (HCC). Both sorafenib and regorafenib were shown to abolish the NF-κB-mediated progression of HCC. However, the effect of lenvatinib on NF-κB-mediated progression of HCC is ambiguous. Therefore, the primary purpose of the present study was to evaluate the inhibitory effect of lenvatinib and its inhibitory mechanism on the NF-κB-mediated progression of HCC in vitro and in vivo. Here, we used two HCC cell lines to identify the cytotoxicity, apoptosis and metastasis effect of lenvatinib. We also applied a Hep3B-bearing animal model to investigate the therapeutic efficacy of lenvatinib on in vivo model. An NF-κB translocation assay, NF-κB reporter gene assay, a Western blotting assay and immunohistochemistry staining were used to investigate the underlying mechanism by which lenvatinib acts on HCC. In this study, we demonstrated that lenvatinib induced extrinsic/intrinsic apoptosis and suppressed the metastasis of HCC both in vitro and in vivo. Lenvatinib may also suppress NF-κB translocation and activation. We also found both protein kinase C delta (PKC-δ) and p38 mitogen-activated protein kinase (MAPK) inactivation participated in lenvatinib-reduced NF-κB signaling. In conclusion, this study reveals that the suppression of PKC-δ, and the p38 MAPK/NF-κB axis is associated with the lenvatinib-inhibited progression of HCC in vitro and in vivo.
Article
Chronic hepatitis B and C are major risk factors for hepatocellular carcinoma (HCC) in the United States and worldwide. Direct and indirect mechanisms of viral infection lead to the development of HCC. Chronic viral infection leads to inflammation and liver damage, culminating in cirrhosis, the penultimate step in the progression toward HCC. Host, viral, and environmental factors likely interact to promote oncogenesis. Clinical considerations include recommendations for screening for HCC in persons at risk, treatment with antivirals, and an emerging role for immunotherapy. We pose unanswered questions regarding HCC susceptibility and pathogenesis in the setting of chronic hepatitis B and C.
Article
Background & objectives: Hepatitis C virus (HCV), an important cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma, shows a considerable genetic heterogeneity among hepatitis C virus isolates from all over the world. At least six main groups of sequence variants are recognized. The natural history of disease and response to treatment may be related to the genotype of HCV in a particular patient. Antigenic differences between genotypes also have implications for optimal design of serological sequencing and confirmatory assays for HCV The present study was undertaken with the objective to find out various genotypes of hepatitis C virus prevalent in Indian patients with chronic hepatitis C infection. Methods: Thirty six consecutive newly diagnosed patients with chronic hepatitis C infection were included in the study. HCV RNA was extracted from the serum by standard guanidinium thiocyanate method. Following reverse transcription and amplification, the HCV genotypes were determined by line probe assay (INNO-LiPA HCV II). Results: Of the 36 patients, genotype 3 was found in 24 (66.6%). Of these 24 patients, 3a was seen in 5 patients (13.8%), 3b in two (5.5%) and mixed subtype 3a and 3b in 17 patients (47.2%). Genotype 1 was found in 5 patients (13.8%), with 1b in 1 and 1a in rest four cases. Two patients (5.5%) were infected with genotype 2 (subtype 2a and mixed subtype 2a, 2b respectively). One (2.7%) was infected with genotype 4 (4a). Mixed genotype infection was found in 4 patients (11.1%). Interpretation & conclusion: The present findings showed that genotype 3 of hepatitis C virus was the most prevalent genotype in patients with chronic hepatitis C in this part of India.